Cancer development frequently coincides with a shift from acute inflammatory tumouricidal mediators, including IL-12 and IFN-γ, to those that are chronically immunosuppressive, such as IL-8, IL-17, IL-23, and IL-13. Here, IFNG is linked to cancer.